Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation
- PMID: 324689
- DOI: 10.2165/00003088-197702020-00005
Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation
Abstract
The plasma protein binding of phenytoin and warfarin was studied in vitro by equilibrium dialysis at 37 degrees C in plasma from patients with chronic renal disease before and after renal transplantation. The plasma protein binding of these two drugs (which is decreased in the uraemic state), increased dramatically during the first 2 to 4 postoperative days and reached values slightly below normal on the 10th to the 15th postoperative day. This increase in binding is suggested to be due to the elimination of inhibiotrs of drug albumin binding, earlier shown to be present in uraemic serum.
Similar articles
-
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.Clin Pharmacol Ther. 1975 Jun;17(6):677-84. doi: 10.1002/cpt1975176677. Clin Pharmacol Ther. 1975. PMID: 1095281
-
Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.Eur J Clin Pharmacol. 1975 Aug 14;8(6):445-53. doi: 10.1007/BF00562320. Eur J Clin Pharmacol. 1975. PMID: 1233247
-
Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.J Pharm Sci. 1977 Sep;66(9):1285-8. doi: 10.1002/jps.2600660920. J Pharm Sci. 1977. PMID: 333094
-
Effect of disease states on plasma protein binding of drugs.Med Clin North Am. 1974 Sep;58(5):1103-9. doi: 10.1016/s0025-7125(16)32106-x. Med Clin North Am. 1974. PMID: 4607741 Review. No abstract available.
-
Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.Ther Drug Monit. 1980;2(4):331-44. Ther Drug Monit. 1980. PMID: 7013166 Review.
Cited by
-
Clinical pharmacokinetics of phenytoin.Clin Pharmacokinet. 1979 May-Jun;4(3):153-69. doi: 10.2165/00003088-197904030-00001. Clin Pharmacokinet. 1979. PMID: 383353 Review.
-
Clinical relevance of pharmacokinetics.Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001. Clin Pharmacokinet. 1980. PMID: 6102499 Review. No abstract available.
-
Plasma protein binding of azapropazone in patients with kidney and liver disease.Br J Clin Pharmacol. 1981 Apr;11(4):361-7. doi: 10.1111/j.1365-2125.1981.tb01133.x. Br J Clin Pharmacol. 1981. PMID: 7259929 Free PMC article.
-
Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.Eur J Drug Metab Pharmacokinet. 1984 Jul-Sep;9(3):275-82. doi: 10.1007/BF03189651. Eur J Drug Metab Pharmacokinet. 1984. PMID: 6519129
-
Clinical pharmacokinetics in organ transplant patients.Clin Pharmacokinet. 1989 Mar;16(3):134-61. doi: 10.2165/00003088-198916030-00002. Clin Pharmacokinet. 1989. PMID: 2656047 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources